Segall Bryant & Hamill’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,277
| Closed | -$1.74M | – | 553 |
|
|
2023
Q2 | $1.74M | Sell |
8,277
-1,037
| -11% | -$218K | 0.02% | 438 |
|
|
2023
Q1 | $1.88M | Sell |
9,314
-1,859
| -17% | -$375K | 0.02% | 430 |
|
|
2022
Q4 | $2.43M | Sell |
11,173
-13,283
| -54% | -$2.89M | 0.03% | 404 |
|
|
2022
Q3 | $4.83M | Sell |
24,456
-91,888
| -79% | -$18.1M | 0.06% | 314 |
|
|
2022
Q2 | $24.9M | Sell |
116,344
-41,117
| -26% | -$8.79M | 0.28% | 103 |
|
|
2022
Q1 | $44.7M | Sell |
157,461
-6,298
| -4% | -$1.79M | 0.43% | 65 |
|
|
2021
Q4 | $61.7M | Sell |
163,759
-4,224
| -3% | -$1.59M | 0.57% | 43 |
|
|
2021
Q3 | $69.3M | Sell |
167,983
-1,170
| -0.7% | -$483K | 0.66% | 32 |
|
|
2021
Q2 | $62.5M | Buy |
169,153
+34,241
| +25% | +$12.7M | 0.61% | 40 |
|
|
2021
Q1 | $39.1M | Buy |
134,912
+2,724
| +2% | +$789K | 0.39% | 71 |
|
|
2020
Q4 | $33M | Buy |
132,188
+30,496
| +30% | +$7.61M | 0.37% | 77 |
|
|
2020
Q3 | $23M | Buy |
101,692
+17,600
| +21% | +$3.99M | 0.31% | 80 |
|
|
2020
Q2 | $14.7M | Buy |
+84,092
| New | +$14.7M | 0.25% | 99 |
|